Drugs / modified allergen extract
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01012752 Comparator | Oct 2016 → Oct 2017 | conjunctivitis, seasonal allergic rhinitis | Roxall | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | modified allergen extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01012752 ↗ |
| Route | Subcutaneous | “subcutaneous injections” NCT01012752 ↗ |